INVESTORS & MEDIA

Corporate Governance

Corporate Governance

Date Name Title Type Shares Traded Price
Sep 18, 2013
Director, President & CEO
Director, President & CEO Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 218,389 $9.49
Sep 18, 2013
Director, President & CEO
Director, President & CEO Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 218,389 --
Dec 15, 2004
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Grant, award or other acquisition pursuant to Rule 16b-3(d) 218,389 --
Jun 20, 2006
Director
Director Bona fide gift 219,801 --
Jun 20, 2006
Director
Director Bona fide gift 219,801 --
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 222,000 --
Dec 17, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 230,350 $179.13
May 12, 2016
Director, Chairman of the Board
Director, Chairman of the Board Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 230,684 $20.32
May 12, 2016
Director, Chairman of the Board
Director, Chairman of the Board Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 230,684 --
Feb 14, 2012
Director, President & CEO
Director, President & CEO Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 234,616 $13.00

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

IR Tools